Table 2.
Pathogen | Total (n = 109) | Percentage |
Staphylococcus spp. | 27 | 24.8% |
Staphylococcus aureus | 19 | 17.4% |
MSSA | 11 | 10.1% |
MRSA | 8 | 7.3% |
CNS (coagulase-negative Staphylococcus) | 8 | 7.3% |
Staphylococcus epidermidis | 4 | 3.7% |
Staphylococcus haemoliticus | 1 | 0.9% |
Staphylococcus lugdudensis | 2 | 1.8% |
Staphylococcus capitis | 1 | 0.9% |
Streptococcus spp. | 28 | 25.7% |
Streptococcus viridans | 14 | 12.8% |
Streptococcus sanguinis | 8 | 7.3% |
Streptococcus mitis | 4 | 3.7% |
Streptococcus anginosus | 1 | 0.9% |
Streptococcus defectivus | 1 | 0.9% |
Streptococcus gallolyticus | 9 | 8.3% |
Former nutritional variants | 2 | 1.8% |
Abiotrofia defective | 1 | 0.9% |
Granulicatella adiacens | 1 | 0.9% |
Other Streptococcaceae | 3 | 2.8% |
Enterococcus faecalis | 11 | 10.1% |
Actinomyces odontolyiticus | 2 | 1.8% |
HACEK group | 2 | 1.8% |
Gram negative other than HACEK | 3 | 2.8% |
Candida spp. | 2 | 1.8% |
Negative blood culture | 34 | 31.1% |
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.